Charleston, SC (openPR) 14 January 2009

The National Association for Continence (NAFC) announced today that it is launching a survey to better assess the impact of overactive bladder (OAB) and views on the treatment of those suffering from this condition. be NAFC survey by an independent led market research and supported by a research grant from Medtronic, Inc., to the knowledge of overactive bladder by specifically increasing patient understand the disease and its consequences affected as manage their OAB symptoms, the emotional burden of overactive bladder patients, and what brings people into treatment.

that 33 million men and women of the overactive bladder, urinary incontinence suffer with a single area of approximately € 12,200,000, 2 However, many people who suffer from this condition can not consult a doctor or do not meet the prescribed treatment of the symptoms. Overactive bladder and incontinence are twice as common in women than men and more common with increasing age.


can

“Overactive bladder is a disease affecting mainly women, the poor quality of life lead, including embarrassment, loss of self-esteem, sleep deprivation and depression or anxiety,” said Nancy Muller, Executive Director of the ANCA. “The results of the survey will help the patients, their relatives and health professionals have a better understanding of the emotional consequences of this condition the victim to express – and what they do, they can overcome.”

ANCA growing interest in studying the emotional impact of overactive bladder in women after the results of the surveys by the organization in 2003 and 2004 are performed. Previous research has examined the prevalence of problems of bladder control in the United States and found that one third of men and women aged 30-70 experienced a loss of control over bladder function at any time, in their adulthood, and perhaps with symptoms.3 live in their national survey of women aged 40-65, the ANCA found that comorbidities occur statistically more frequently in patients with symptoms of overactive bladder, than those without symptoms of overactive bladder. In addition, we learned that many women do not stay on their medication disadvantages of overactive bladder, although users no symptoms less serious offenses than those who stay with the current prescribed medications reported to alleviate symptoms. > 4

The International Continence Society (ICS) defines overactive bladder as “urgent, with or without incontinence, usually with urinary frequency and nocturia. Typical symptoms include urinating more than eight times per day (frequency) or more than once at night (nocturia) and a strong sudden urge to urinate (urine) .5 There are several forms of overactive bladder, including, but not too wet OAB or urge incontinence (involuntary loss of urine) and dry OAB without urgency urinary incontinence is limited (urination with the ability to control the urge) .5

the emotional impact of OAB on patients’ lives and health can be severe. People with incontinence problems faced often see with simple, everyday activities such as work, shopping, traveling by car or a movie, for fear of embarrassing wetting episodes or may not be near a toilet. Therefore, many patients suffer from OAB negative impact on their emotional well-being and their ability to feel comfortable at work or in social situations. > 5

“Medtronic proud to work with the NAFC is to support this important research,” said Cindy Kent, Group Marketing Director of Gastroenterology and urology therapies Medtronic, Inc. “We are the fate of the ATO committed shadow, and the to draw support for this survey, the attention to the needs of people with an overactive bladder, while encouraging them to explore possibilities for appropriate treatment. “

About the study

online interviews will be administered to women in the United States are 18 years and in three subgroups: those with contracts that are currently used shared disadvantages for the treatment of overactive bladder, and those who previously used for the treatment of overactive bladder were treated and those who were never treated for overactive bladder.

About the National Association for Continence (NAFC)

NAFC is a 501 (c) 3 whose mission is threefold: 1) educating the public about the causes, diagnosis categories, treatment options and alternatives, and management of bladder control colon problems, bladder dysfunction, bed wetting, and pelvic floor disorders, 2) to network with other organizations and institutions to increase the visibility and priority to these areas, and 3) defend the interests of consumers from such symptoms as a result of disease or other illness, obstetrical, surgical or other trauma, or damage suffering through the aging process itself. NAFC is broadly funded by consumers, health professionals and the industry. It is the largest and most productive in the world organization of consumers devoted exclusively to this area.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the world leader in medical technology – to relieve pain, restoring health and extending life for millions of people around the world at large. Medtronic developed and leads the field of neuromodulation, the targeted and controlled electrical pulses and pharmaceuticals to specific sites in the nervous system. Neuromodulation business of the company, offers innovative therapies for chronic pain, movement disorders, spasticity, overactive bladder, benign prostate and gastroparesis. Medtronic Interstim therapy for the treatment of urinary retention and symptoms of overactive bladder, including urinary incontinence and significant symptoms of urgency-frequency alone or in combination in patients who have failed to tolerate or could not specify, more conservative treatments.

References:

1 W Stewart, JB Van Rooyen, GW Cundiff, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 20 (6) :327-336.

2 Stewart W, et al. Prevalence and impact of overactive bladder in the United States: results from the Noble Program. Neurological Urodynamics.

2001, 20:406-408.

3 N. Muller What the Americans understand how it affects the control of bladder function problems: Highlights of recent research and consuming countries. Urologic Nursing. 2005:25 (2): 109-115.

4 poll shows Communication Gap between caregivers and women with overactive bladder. Urologic Nursing. 2004:24 (1): 64

5 “urge incontinence / overactive bladder.” ANCA website. http://www.nafc.org/bladder-bowel-health/types-of-incontinence/urge-incontinence/. Retrieved 13th November 2008.


P

###
clear = “all”
OAB